[EUROASPIRE III: a comparison between Turkey and Europe]

Author(s): TokgÃzoÄŸlu L, Kaya EB, Erol C, Ergene O; EUROASPIRE III Turkey Study Group


Objectives:The EUROASPIRE III survey was conducted in 2006-2007 in 22 countries in Europe (76 centers) to describe risk factors, lifestyle and therapeutic management of patients with coronary heart disease (CHD), compliance with current guidelines, and to document changes over time. This study aimed to assess the results of the EUROASPIRE III survey in terms of differences between Turkey and other European countries.

Study design:The results of the EUROASPIRE III survey were compared with those of 17 centers from Turkey. Consecutive patients with a diagnosis of CHD (669 medical records, 23.8% women) were identified retrospectively, of which 338 patients (50.5%) were followed-up, interviewed, and examined at least six months after the index event (acute coronary syndrome or interventional procedure).

Results:Compared to the EUROASPIRE III data, recordings from Turkey's centers at discharge on classical risk factors did not exhibit remarkable differences; however, data on weight, height, waist circumference, lipid profile, glucose, and HbA1c measurements were more incomplete. In comparison to Europe population, the most important differences were observed in the higher rates of the following: young patients with myocardial infarction (>50 years, 20% vs. 12.7%), persistence in smoking (23.1% vs. 17.2%), immobility, low HDL-cholesterol (50.2% vs. 36.7%), insufficient follow-up by physicians after the index event (12% vs. 2.2%-except Turkey), and insufficient patient education.

Conclusion:The data from the Turkey arm of the survey show that efforts for cardiovascular disease prevention fall short of the targets, similar to Europe.

Similar Articles

Prevalence, awareness, treatment and control of hypertension in Turkey (the Patent study) in 2003

Author(s): Altun B, Arici M, NergizoAYlu G, Derici U, Karatan O, et al.

Differences in quality of life in men and women with ischemic heart disease

Author(s): Westin L, Carlsson R, Erhardt L, Cantor-Graae E, McNeil T